• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Digital Therapeutics Global Market to Reach $13.9 Billion

Article

ResearchAndMarkets.com releases "Digital Therapeutics: A New Age Medicine"

ResearchAndMarkets.com’s "Digital Therapeutics: A New Age Medicine" report expects the digital therapeutics (DTx) global market to reach $13.9 billion by 2027, at a 28.1% CAGR. DTx is considered a subset of digital health and factors for its growth include tools that allow for better involvement of the patient in the management of the disease, specifically in chronic diseases; increased investment this space; growing research activities, and the increasing use of smartphones, mhealth apps, and wearables.

Read more about the DTx market.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.